Project Number T-PEP-20-672021 Agency/Funding Organization Alzheimer's Association|Tau Consortium Funding Year 2020 View Full Project Details for Farnesyl transferase inhibitors to treat tauopathies Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Kosik, Kenneth Principal Investigator First Name Kenneth Principal Investigator Last Name Kosik Awardee Organization The Regents of the University of California, Santa Barbara Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2020: T-PEP RFA FY Overall Cost $750,000 Funding Organization Agency/Funding Organization Alzheimer's Association|Tau Consortium Program Official Murtishaw, Andrew asmurtishaw@alz.org
